Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brad Shumel
Dupilumab Improves Outcomes of Concurrent Asthma and Chronic Sino-Nasal Conditions in Patients With Atopic Dermatitis—a Pooled Analysis of Four Phase 3 Studies (LIBERTY AD SOLO 1 & 2, CHRONOS, and CAFÉ)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
Laboratory Safety of Dupilumab in Moderate‐to‐severe Atopic Dermatitis: Results From Three Phase III Trials ( LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS )
British Journal of Dermatology
Dermatology
Medicine
Pss43 - Dupilumab Improves Absenteeism in Moderate-To-Severe Atopic Dermatitis Patients Compared With Placebo in Phase 3 Liberty Ad Solo Studies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dupilumab in Moderate-To-Severe Atopic Dermatitis With or Without Comorbid Food Allergy: Pooled Analysis of 2 Randomized Phase 3 Trials (LIBERTY AD SOLO 1 & 2)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Dupilumab Improves Nasal Polyp Burden and Asthma Control in Patients With CRSwNP and AERD
Journal of Allergy and Clinical Immunology: In Practice
Allergy
Immunology
673 Real-World Persistence With Dupilumab Among Adults With Atopic Dermatitis (AD)
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Group 2 Innate Lymphoid Cells in Patients With Severe Atopic Dermatitis on Dupilumab
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Dupilumab Consistently Improves Rhinoconjunctivitis-Specific Health-Related Quality of Life in Patients With Uncontrolled, Moderate-To-Severe Asthma and Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-To-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
